{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:56:03Z","timestamp":1791352563591,"version":"4.3.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jbo.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T08:25:11Z","timestamp":1450340711000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status"],"prefix":"10.1016","volume":"5","author":[{"given":"Pierre","family":"Avril","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Rom\u00e9e","family":"Le Nail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meadhbh \u00c1.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzague","family":"De Pinieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Layrolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Trichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2015.11.002_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.9-4-422","article-title":"Biology and therapeutic advances for pediatric osteosarcoma","volume":"9","author":"Marina","year":"2004","journal-title":"Oncologist."},{"key":"10.1016\/j.jbo.2015.11.002_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-2-6","article-title":"Osteosarcoma (osteogenic sarcoma)","volume":"2","author":"Picci","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jbo.2015.11.002_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","article-title":"Osteosarcoma treatment-where do we stand? A state of the art review","volume":"40","author":"Luetke","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbo.2015.11.002_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11999-007-0055-9","article-title":"Allograft-prosthetic composite in the proximal tibia after bone tumor resection","volume":"466","author":"Donati","year":"2008","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1302\/0301-620X.75B6.8245080","article-title":"Massive allografts sterilised by irradiation. Clinical results","volume":"75","author":"Hernigou","year":"1993","journal-title":"J. Bone Jt. Surg. Br."},{"key":"10.1016\/j.jbo.2015.11.002_bib6","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.2106\/JBJS.M.00655","article-title":"Intercalary allograft reconstructions following resection of primary bone tumors: a nationwide multicenter study","volume":"96","author":"Bus","year":"2014","journal-title":"J. Bone Jt. Surg. Am."},{"key":"10.1016\/j.jbo.2015.11.002_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1302\/0301-620X.97B6.34692","article-title":"The vascularised fibular graft for limb salvage after bone tumour surgery: a multicentre study","volume":"97","author":"Hilven","year":"2015","journal-title":"Bone Jt. J."},{"key":"10.1016\/j.jbo.2015.11.002_bib8","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s11999-009-1024-2","article-title":"Megaprosthesis versus Condyle-sparing intercalary allograft: distal femoral sarcoma","volume":"467","author":"Zimel","year":"2009","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2015.11.002_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/scrt504","article-title":"Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate","volume":"5","author":"Brennan","year":"2014","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.jbo.2015.11.002_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1023\/A:1008221713505","article-title":"Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy","volume":"8","author":"Ferrari","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbo.2015.11.002_bib12","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1016\/j.biomaterials.2014.08.018","article-title":"Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages","volume":"35","author":"Gamblin","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbo.2015.11.002_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.1992.10.1.5","article-title":"Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience","volume":"10","author":"Meyers","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2015.11.002_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/stem.1903","article-title":"Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas","volume":"33","author":"Grisendi","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2015.11.002_bib15","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1111\/j.1582-4934.2008.00317.x","article-title":"Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model","volume":"12","author":"Mohr","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jbo.2015.11.002_bib16","first-page":"787","article-title":"Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers","volume":"1","author":"Grisendi","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib17","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.E02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.jbo.2015.11.002_bib18","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/PRS.0b013e3181babbb6","article-title":"Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells","volume":"124","author":"Lu","year":"2009","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.jbo.2015.11.002_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00266-007-9019-4","article-title":"Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem\/stromal cells","volume":"32","author":"Yoshimura","year":"2008","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.jbo.2015.11.002_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/1090820X11415976","article-title":"Autologous fat transplantation versus adipose-derived stem cell-enriched lipografts: a study","volume":"31","author":"Sterodimas","year":"2011","journal-title":"Aesthetic Surg. J."},{"key":"10.1016\/j.jbo.2015.11.002_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejso.2012.02.178","article-title":"Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial","volume":"38","author":"Perez-Cano","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.jbo.2015.11.002_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/2000656X.2012.668326","article-title":"Importance of mesenchymal stem cells in autologous fat grafting: a systematic review of existing studies","volume":"46","author":"Trojahn Kolle","year":"2012","journal-title":"J. Plast. Surg. Hand Surg."},{"key":"10.1016\/j.jbo.2015.11.002_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/SAP.0b013e31822d9e04","article-title":"Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention","volume":"68","author":"Yingbo","year":"2012","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.jbo.2015.11.002_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2106\/JBJS.G.00292","article-title":"Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model","volume":"90","author":"Hsu","year":"2008","journal-title":"J. Bone Jt. Surg. Am."},{"key":"10.1016\/j.jbo.2015.11.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.05.027","article-title":"Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy","volume":"325","author":"Burns","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbo.2015.11.002_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.559","article-title":"Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?","volume":"29","author":"Klopp","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbo.2015.11.002_bib27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1349-7006.2010.01731.x","article-title":"Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2","volume":"101","author":"Bian","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbo.2015.11.002_bib28","first-page":"163","article-title":"Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model","volume":"40","author":"Tsukamoto","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbo.2015.11.002_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2009.02.022","article-title":"Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis","volume":"281","author":"Xu","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbo.2015.11.002_bib30","doi-asserted-by":"crossref","first-page":"e10999","DOI":"10.1371\/journal.pone.0010999","article-title":"Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence","volume":"5","author":"Perrot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2015.11.002_bib31","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/0008-5472.CAN-09-4291","article-title":"Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases","volume":"70","author":"Endo-Munoz","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib32","first-page":"434","article-title":"The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis","volume":"2012","author":"Endo-Munoz","year":"1826","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.jbo.2015.11.002_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bone.2005.02.020","article-title":"Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma","volume":"37","author":"Heymann","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2015.11.002_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/cgt.2009.89","article-title":"Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models","volume":"17","author":"Rousseau","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jbo.2015.11.002_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00453875","article-title":"Long-term survival of fat transplants: controlled demonstrations","volume":"19","author":"Coleman","year":"1995","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.jbo.2015.11.002_bib36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00266-013-0126-0","article-title":"Evaluation of the histologic changes in the fat-grafted facial skin: clinical trial","volume":"37","author":"Covarrubias","year":"2013","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.jbo.2015.11.002_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.asj.2009.08.010","article-title":"Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years","volume":"29","author":"Delay","year":"2009","journal-title":"Aesthetic Surg. J."},{"key":"10.1016\/j.jbo.2015.11.002_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/ten.tec.2010.0387","article-title":"Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum","volume":"17","author":"Cordonnier","year":"2011","journal-title":"Tissue Eng. Part C. Methods"},{"key":"10.1016\/j.jbo.2015.11.002_bib39","doi-asserted-by":"crossref","first-page":"045019","DOI":"10.1088\/1748-6041\/10\/4\/045019","article-title":"3D cell culture and osteogenic differentiation of human bone marrow stromal cells plated onto jet-sprayed or electrospun micro-fiber scaffolds","volume":"10","author":"Brennan","year":"2015","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.jbo.2015.11.002_bib40","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1210\/en.2007-1719","article-title":"Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3","volume":"149","author":"Duplomb","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbo.2015.11.002_bib41","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1074\/jbc.271.25.14764","article-title":"Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein","volume":"271","author":"Chevalier","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbo.2015.11.002_bib42","doi-asserted-by":"crossref","first-page":"e90795","DOI":"10.1371\/journal.pone.0090795","article-title":"Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models","volume":"9","author":"Gobin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2015.11.002_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jbo.2015.11.002_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jbo.2015.11.002_bib45","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/jbmr.455","article-title":"Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models. Journal of bone and mineral research: the official journal of the American","volume":"26","author":"Rousseau","year":"2011","journal-title":"Soc. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1593\/neo.05394","article-title":"Stem-like cells in bone sarcomas: implications for tumorigenesis","volume":"7","author":"Gibbs","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbo.2015.11.002_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tvjl.2007.07.025","article-title":"Isolation and characterisation of cancer stem cells from canine osteosarcoma","volume":"175","author":"Wilson","year":"2008","journal-title":"Vet. \u2013 J."},{"key":"10.1016\/j.jbo.2015.11.002_bib48","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1158\/0008-5472.CAN-08-3580","article-title":"Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma","volume":"69","author":"Levings","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib49","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/0008-5472.CAN-13-0530","article-title":"Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer","volume":"73","author":"Bochet","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/ATVBAHA.109.188318","article-title":"Preconditioning by mitochondrial reactive oxygen species improves the proangiogenic potential of adipose-derived cells-based therapy","volume":"29","author":"Carriere","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbo.2015.11.002_bib51","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","article-title":"Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells","volume":"109","author":"Rehman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jbo.2015.11.002_bib52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1541-7786.MCR-11-0347","article-title":"Fibroblast growth factor-2 is an important factor that maintains cellular immaturity and contributes to aggressiveness of osteosarcoma","volume":"10","author":"Shimizu","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib53","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1038\/onc.2008.218","article-title":"Matrix metalloproteinase-11\/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions","volume":"27","author":"Motrescu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbo.2015.11.002_bib54","doi-asserted-by":"crossref","first-page":"e9741","DOI":"10.1371\/journal.pone.0009741","article-title":"Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts","volume":"5","author":"David","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2015.11.002_bib55","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","article-title":"Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion","volume":"71","author":"Dirat","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib56","doi-asserted-by":"crossref","first-page":"E2595","DOI":"10.1073\/pnas.1212834109","article-title":"ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium","volume":"109","author":"Nguyen-Ngoc","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jbo.2015.11.002_bib57","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3892\/or.2013.2619","article-title":"CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF","volume":"30","author":"Zhang","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbo.2015.11.002_bib58","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1158\/0008-5472.CAN-06-4130","article-title":"Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption","volume":"67","author":"Lamoureux","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib59","doi-asserted-by":"crossref","first-page":"e45590","DOI":"10.1371\/journal.pone.0045590","article-title":"Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis","volume":"7","author":"Waterman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2015.11.002_bib60","article-title":"Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model?","author":"Aanstoos","year":"2015","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jbo.2015.11.002_bib61","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2106\/JBJS.M.00261","article-title":"Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate","volume":"95","author":"Hernigou","year":"2013","journal-title":"J. Bone Jt. Surg. Am."},{"key":"10.1016\/j.jbo.2015.11.002_bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/157488811797904371","article-title":"Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique","volume":"6","author":"Centeno","year":"2011","journal-title":"Curr. Stem Cell. Res. Ther."},{"key":"10.1016\/j.jbo.2015.11.002_bib63","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00264-014-2384-0","article-title":"Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?","volume":"38","author":"Hernigou","year":"2014","journal-title":"Int. Orthop."},{"key":"10.1016\/j.jbo.2015.11.002_bib64","article-title":"Opposite effects of soluble factors secreted by adipose tissue on proliferating and quiescent osteosarcoma cells","author":"Avril","year":"2015","journal-title":"Plast. Reconstr. Surg."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137415300373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137415300373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T16:28:30Z","timestamp":1567441710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137415300373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2212137415300373"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2015.11.002","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier GmbH","name":"copyright","label":"Copyright"}]}}